8.75
12.15%
-1.21
Dopo l'orario di chiusura:
8.65
-0.10
-1.14%
Candel Therapeutics Inc Azioni (CADL) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | 0.102 |
Operating Expenses
|
23.42%
7.902
|
10.32 | 8.861 | 9.579 | 9.633 |
Interest Income/Expense |
4.01%
0.646
|
0.673 | 0.669 | 0.644 | 0.609 |
Operating Income/Loss |
23.42%
-7.902
|
-10.32 | -8.861 | -9.579 | -9.633 |
Nonoperating Income/Loss |
58.94%
-0.319
|
-0.777 | 0.426 | -0.035 | 0.838 |
Income/Loss From Continuing Operations Before Tax |
25.90%
-8.221
|
-11.10 | -8.435 | -9.614 | -8.795 |
Income/Loss From Continuing Operations After Tax |
25.90%
-8.221
|
-11.10 | -8.435 | -9.614 | -8.795 |
Net Income/Loss
|
25.90%
-8.221
|
-11.10 | -8.435 | -9.614 | -8.795 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
188.53K%
29.20
|
0.0155 | 28.92 | 28.92 | 28.92 |
Diluted Average Shares |
188.53K%
29.20
|
0.0155 | 28.92 | 28.92 | 28.92 |
Basic Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.29 | -0.33 | -0.30 |
Diluted Earnings Per Share |
26.32%
-0.28
|
-0.38 | -0.29 | -0.33 | -0.30 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):